Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
2.900
-0.540 (-15.70%)
Mar 31, 2025, 1:15 PM EDT - Market open

Silence Therapeutics Stock Forecast

SLN's stock price has decreased by -86.57% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 40.8, with a low estimate of 4.00 and a high estimate of 75. The average target predicts an increase of 1,306.90% from the current stock price of 2.90.

Analyst Consensus: Buy
Target Low Average Median High
Price $4.00 $40.8 $45 $75
Change +37.93% +1306.9% +1451.7% +2486.2%

Analyst Ratings

The average analyst rating for Silence Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222222
Buy 222212
Hold 000000
Sell 000000
Strong Sell 000011
Total 444445

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$75
Strong Buy Reiterates $75 +2,486.21% Mar 7, 2025
Morgan Stanley
Morgan Stanley
Buy
Maintains
$49$45
Buy Maintains $49$45 +1,451.72% Mar 5, 2025
BMO Capital
BMO Capital
Buy
Maintains
$67$25
Buy Maintains $67$25 +762.07% Mar 4, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Maintains
$6$4
Strong Sell Maintains $6$4 +37.93% Mar 4, 2025
Goldman Sachs
Goldman Sachs
Strong Sell
Initiates
$6
Strong Sell Initiates $6 +106.90% Feb 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
32.34M
from 43.26M
Decreased by -25.23%
Revenue Next Year
n/a
from 32.34M
EPS This Year
n/a
from -0.98
EPS Next Year
n/a
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
5.48M12.42M21.66M31.64M43.26M32.34M
Revenue Growth
2,145.49%126.59%74.43%46.12%36.71%-25.23%
EPS
-1.19-1.33-1.56-1.46-0.98-
EPS Growth
------
Forward PE
------
No. Analysts -----6
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2025
High 74.5M
Avg 32.3M
Low 10.3M

Revenue Growth

Revenue Growth 2025
High
72.2%
Avg
-25.2%
Low
-76.3%

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.